National Drug Authority (NDA) secured a conviction on April 5, 2018 against Fred Job Niyonzima who was charged with unlawful possession of classified drugs (Avastin and Stutent), carrying out the business of supplying restricted drugs and importing drugs without a license. The case was brought to NDA’s attention by members of the public in September…Details
Press Statement on Final investigations Report on suspected falsified Hepatitis B vaccine found on the Ugandan market in March 2018
The Ministry of Health would like to inform the general public that it has concluded investigations into the suspected falsified vaccines found on the Ugandan market in March this year. This follows field investigations, laboratory investigations and enforcement activities undertaken by NDA with support of the Ministry of Health, National Medical Stores (NMS), the Health…Details
Background NDA is mandated to ensure that the population of Uganda has access to safe, effective and quality drugs We received market complaints on quality of different pharmaceutical products. Some of the complaints were related to the occurrence of serious adverse events whereas other products had critical quality defects posing a risk to public health.…Details
The Secretary to the Authority in a met with Dan Hartmann and David Mukanga from the Gates Foundation on Friday, October 5th 2018 Discussions were on a number of issues geared towards enhancing regulatory Harmonization and local manufacturing of pharmaceuticals. In attendance was the Ag. Manager, Harmonization.Details
National Drug Authority (NDA) participated in the registration of a veterinary vaccine submitted under the East African Community (EAC) Mutual Recognition Procedure (MRP) The Process that resulted in licensing of a vaccine known as Bioral H120 NeO manufactured by Merial, France which will be marketed across all the EAC member countries. The vaccine protects poultry…Details
NDA staff during radio talk show at UBC radio station to commemorate World Animal Day. Some of the talking points were about NDA roles in regulation of veterinary drugs, acaricide resistance and World Animal Day.